Related Experiment Video
Updated: Aug 19, 2025

08:23
CIRCLE-Seq for Interrogation of Off-Target Gene Editing
Published on: November 1, 2024
795
Automated high-throughput genome editing platform with an AI learning in situ prediction model
Siwei Li1,2, Jingjing An1,2, Yaqiu Li1,2
1Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin, China.
Nature Communications
|November 30, 2022
Summary
Researchers developed an automated platform for high-throughput genome editing, creating thousands of edited cells weekly. They also created a model to predict base editor performance, accelerating genetic therapy development.
Area of Science:
- Genetics
- Bioengineering
- Computational Biology
Background:
- Generating cell disease models with pathogenic single nucleotide variants (SNVs) is crucial for developing genome editing therapeutics and basic research.
- Traditional methods for creating these models are manual, time-consuming, costly, and prone to errors.
Purpose of the Study:
- To develop an automated high-throughput platform for efficient generation of genome-edited cells.
- To create a predictive model for cytosine base editor (CBE) performance using genome editing data.
Main Methods:
- An automated high-throughput platform was designed to perform large-scale in situ genome editing.
- A Chromatin Accessibility Enabled Learning Model (CAELM) was developed, integrating chromatin accessibility and sequence context data.
- The model was trained on data generated by the automated platform to predict CBE editing outcomes.
Main Results:
- The automated platform successfully generated thousands of edited cell samples with high efficiency within a week.
- The CAELM accurately predicted the performance of in situ base editing.
- The model effectively utilized both chromatin accessibility and sequence context for prediction.
Conclusions:
- The automated platform significantly enhances the efficiency and scalability of generating genome-edited cell models.
- The CAELM provides an accurate method for predicting base editor performance, reducing experimental trial and error.
- This integrated approach is expected to accelerate the development and application of base editor-based genetic therapies.
Related Concept Videos
CRISPR/Cas9 Genome Editing
132
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
132
CRISPR
52.7K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.7K
CRISPR and crRNAs
17.3K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.3K

